Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11300908 | 0.88 | AOC3 (0.46) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL30056339 | 0.88 | AOC3 (0.46) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL9723471 | 0.85 | AOC3 (0.41) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL18189126 | 0.85 | KDM4E (0.44) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL7274253 | 0.84 | SLC2A1 (0.45) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL18189127 | 0.84 | KDM4E (0.47) | AOC3SMN1; SMN2POLBKDM4EALDH1A1 | |
| SCHEMBL697386 | 0.83 | KMT2A (0.48) | POLBOPRD1KDM4ETSHRPDE4A | |
| SCHEMBL20147971 | 0.83 | PDCD1 (0.46) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL8910900 | 0.82 | AOC3 (0.56) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 | |
| SCHEMBL7274336 | 0.82 | PDE4A (0.42) | AOC3SMN1; SMN2POLBCYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117964834-A | Polyacrylate polymers | 巴斯夫欧洲公司 | 2024-05-03 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| CN-121428030-A | Preparation method and application of eicosapentaenoic acid-trimethoxybenzyl alcohol ester | 马丁·格哈特·班威尔 | 2026-01-30 | — | — | CN | disclosed |
| US-20250215037-A1 | ELECTROCHEMICALLY-CLEAVABLE LINKERS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2025-07-03 | — | — | US | disclosed |
| US-12281134-B2 | Electrochemically-cleavable linkers | MICROSOFT TECHNOLOGY LICENSING, LLC (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250115635-A1 | LINKER STRUCTURES WITH MINIMAL SCAR FOR ENZYMATIC SYNTHESIS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2025-04-10 | — | — | US | disclosed |
| CN-119775228-A | Simple and convenient method for preparing trimetazidine | 北京化工大学 | 2025-04-08 | — | — | CN | disclosed |
| US-12215121-B2 | Linker structures with minimal scar for enzymatic synthesis | MICROSOFT TECHNOLOGY LICENSING, LLC (US) | 2025-02-04 | — | — | US | disclosed |
| CN-117964834-A | Polyacrylate polymers | 巴斯夫欧洲公司 | 2024-05-03 | — | — | CN | disclosed |
| EP-4272000-A2 | LINKER STRUCTURES WITH MINIMAL SCAR FOR ENZYMATIC SYNTHESIS | Microsoft Technology Licensing LLC (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-0109816-A1 | N-substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process | ELI LILLY AND COMPANY (US) | 1984-05-30 | — | — | EP | disclosed |
| EP-0109301-A2 | 7-(S)-acylaminocephalosporin sulfones and process | ELI LILLY AND COMPANY (US) | 1984-05-23 | — | — | EP | disclosed |
| EP-0109300-A2 | Desacetylcephalosporin sulfones | ELI LILLY AND COMPANY (US) | 1984-05-23 | — | — | EP | disclosed |
| US-4436596-A | N-Substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process | ELI LILLY AND COMPANY (US) | 1984-03-13 | — | — | US | disclosed |
| EP-0093010-A2 | Alpha-hydroxyethylphosphinates, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-11-02 | — | — | EP | disclosed |
| EP-0004881-B1 | PROCESS FOR THE PREPARATION OF AROMATIC AND ARALIPHATIC ALDEHYDES | BASF Aktiengesellschaft (DE) | 1981-10-07 | — | — | EP | disclosed |
| US-4239702-A | REACTING A BENZOIC ACID WITH ETHYL OR ISOBUTYL CHLOROFORMATE, HYDROGENATION, OPTIONAL OXIDATION | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1980-12-16 | — | — | US | disclosed |
| US-4224254-A | OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| EP-0004881-A2 | Process for the preparation of aromatic and araliphatic aldehydes | BASF Aktiengesellschaft (DE) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115635-A1 | LINKER STRUCTURES WITH MINIMAL SCAR FOR ENZYMATIC SYNTHESIS | RNGTT, MMP1, UNG | AOC3 719/4885SMN1; SMN2 2921/4885POLB 98/4885 |
| US-20250215037-A1 | ELECTROCHEMICALLY-CLEAVABLE LINKERS | RNGTT, DNPEP, DTYMK | AOC3 629/4885SMN1; SMN2 3794/4885POLB 17/4885 |
| US-12281134-B2 | Electrochemically-cleavable linkers | RNGTT, DNPEP, DTYMK | AOC3 629/4885SMN1; SMN2 3794/4885POLB 17/4885 |
| US-12215121-B2 | Linker structures with minimal scar for enzymatic synthesis | RNGTT, MMP1, UNG | AOC3 719/4885SMN1; SMN2 2921/4885POLB 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.